Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ·Healthcare·Biotechnology
$14.09
-1.54%
Mkt Cap $1.21B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (6 analysts)
$35.00
Range $35.00 – $35.00
Implied Upside
+148.4%
Consensus $35.00 vs current $14.09
NASDAQ·Healthcare·Biotechnology
$14.09
-1.54%
Mkt Cap $1.21B
Buy
10
Hold
0
Sell
0
Price Target (6 analysts)
$35.00
Range $35.00 – $35.00
+148.4%
Consensus $35.00 vs current $14.09